Trial Profile
A phase I trial of IPX 159 in healthy volunteers in the USA.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 12 May 2011
Price :
$35
*
At a glance
- Drugs IPX 159 (Primary)
- Indications Restless legs syndrome
- Focus Adverse reactions
- 12 May 2011 New trial record